TG Therapeutics, Inc. (TGTX)
Largest Insider Buys in Sector
TGTX Stock Price History Chart
TGTX Stock Performance
About TG Therapeutics, Inc.
TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hodgkin lymphoma, chronic lymphocytic leukemia (CLL), and relapsing forms of multiple sclerosis; and Umbralisib, an oral inhibitor of PI3K-delta and CK1-epsilon for the treatment of CLL, marginal zone lymphoma, and follicular lymphoma. The company also develops Cosibelimab, a human monoclonal antibody of IgG1 subtype that binds to programmed death-ligand 1 (PD-L1) and blocks its interactions with PD-1 and B7.1 receptors; TG-1701 is an orally available and covalently-bound Bruton's tyrosine kinase (BTK) inhibitor that exhibits selectivity to BTK compared to ibrutinib in in vitro kinase screening; and TG-1801, a bispecific CD47 and CD19 antibody. In addition, it has various licensed preclinical programs for BET, interleukin-1 receptor associated kinase-4, and GITR; and collaboration agreements with Checkpoint Therapeutics, Inc., Jiangsu Hengrui Medicine Co., Novimmune SA, Ligand Pharmaceuticals Incorporated, and Jubilant Biosys. The company has strategic alliances with LFB Biotechnologies S.A.S; GTC Biotherapeutics; LFB/GTC LLC; Ildong Pharmaceutical Co. Ltd.; and Rhizen Pharmaceuticals, S A. TG Therapeutics, Inc. was incorporated in 1993 and is headquartered in New York, New York.
Insider Activity of TG Therapeutics, Inc.
Over the last 12 months, insiders at TG Therapeutics, Inc. have bought $1.01M and sold $2.01M worth of TG Therapeutics, Inc. stock.
On average, over the past 5 years, insiders at TG Therapeutics, Inc. have bought $554,380 and sold $2.72M worth of stock each year.
Highest buying activity among insiders over the last 12 months: WEISS MICHAEL S (CEO and President) — $2.03M.
The last purchase of 100,000 shares for transaction amount of $1.01M was made by WEISS MICHAEL S (CEO and President) on 2023‑08‑11.
List of Insider Buy and Sell Transactions, TG Therapeutics, Inc.
| 2024-06-20 | Sale | Lonial Sagar | director | 16,348 0.011% | $16.87 | $275,791 | +8.42% | |
| 2024-06-17 | Sale | Lonial Sagar | director | 9,585 0.0063% | $16.39 | $157,098 | +6.52% | |
| 2024-03-13 | Sale | Lonial Sagar | director | 5,000 0.0033% | $15.94 | $79,675 | +0.89% | |
| 2024-03-12 | Sale | Charney Laurence N | director | 22,000 0.0144% | $15.97 | $351,340 | +0.16% | |
| 2024-01-05 | Sale | Charney Laurence N | director | 17,500 0.0112% | $19.03 | $333,025 | -19.25% | |
| 2024-01-03 | Sale | Power Sean A | CFO | 47,867 0.0318% | $16.91 | $809,431 | -5.93% | |
| 2023-08-11 | WEISS MICHAEL S | CEO and President | 100,000 0.0669% | $10.13 | $1.01M | +44.87% | ||
| 2023-06-23 | Sale | Lonial Sagar | director | 34,854 0.0246% | $23.37 | $814,538 | -36.10% | |
| 2023-06-02 | Sale | Power Sean A | Chief Financial Officer | 73,647 0.0528% | $26.70 | $1.97M | -43.22% | |
| 2023-01-06 | Echelard Yann | director | 9,000 0.0063% | $10.64 | $95,760 | +44.54% | ||
| 2023-01-04 | Sale | Charney Laurence N | director | 30,000 0.0221% | $11.10 | $333,000 | +43.66% | |
| 2022-01-05 | Sale | WEISS MICHAEL S | CEO and President | 30,671 0.0239% | $18.31 | $561,586 | -57.97% | |
| 2022-01-05 | Sale | Power Sean A | CFO, Secretary and Treasurer | 9,653 0.0075% | $18.31 | $176,746 | -57.97% | |
| 2022-01-04 | Sale | WEISS MICHAEL S | CEO and President | 37,549 0.0281% | $19.20 | $720,941 | -61.45% | |
| 2022-01-04 | Sale | Power Sean A | CFO, Secretary and Treasurer | 75,312 0.0564% | $19.20 | $1.45M | -61.45% | |
| 2020-12-10 | Sale | Echelard Yann | director | 30,000 0.025% | $40.05 | $1.2M | -10.03% | |
| 2020-09-09 | Sale | RA CAPITAL MANAGEMENT, L.P. | 10 percent owner | 158,589 0.1337% | $25.81 | $4.09M | +46.17% | |
| 2020-06-17 | Sale | KENNEDY WILLIAM JAMES | director | 7,745 0.007% | $18.27 | $141,501 | +85.52% | |
| 2019-07-01 | Sale | Power Sean A | CFO, Secretary and Treasurer | 17,654 0.0187% | $8.47 | $149,529 | +7.05% | |
| 2019-06-26 | WEISS MICHAEL S | CEO and President | 50,000 0.0581% | $7.04 | $351,750 | +34.60% |
Insider Historical Profitability
| WEISS MICHAEL S | CEO and President | 12073021 7.9737% | $17.73 | 6 | 3 | +76.33% |
| Power Sean A | CFO | 606969 0.4009% | $17.73 | 2 | 21 | |
| Charney Laurence N | director | 215229 0.1567% | $17.73 | 0 | 4 | |
| Lonial Sagar | director | 105195 0.062% | $17.73 | 0 | 4 | |
| RA CAPITAL MANAGEMENT, L.P. | 10 percent owner | 12629868 8.3415% | $17.73 | 0 | 1 | |
| LFB Biotechnologies S.A.S.U. | 10 percent owner | 5114855 3.3781% | $17.73 | 1 | 0 | +3.39% |
| GIMBERT JOAN PONS | 3957037 2.6135% | $17.73 | 0 | 1 | ||
| ROSENWALD LINDSAY A MD | 10 percent owner | 2649321 1.7498% | $17.73 | 59 | 0 | |
| WEISER MICHAEL | director | 2213338 1.4618% | $17.73 | 1 | 0 | |
| Echelard Yann | director | 201848 0.1333% | $17.73 | 1 | 1 | +44.54% |
| KENNEDY WILLIAM JAMES | director | 94633 0.0625% | $17.73 | 0 | 4 | |
| Herskowitz Neil | director | 51265 0.0339% | $17.73 | 8 | 0 | +168.29% |
| ABEL DOUGLAS | President and CEO | 30000 0.0198% | $17.73 | 8 | 0 |
Institutional Investor Ownership
| The Vanguard Group | $205.9M | 8.76 | 13.54M | -0.98% | -$2.04M | <0.01 | |
| BlackRock | $164.93M | 7.02 | 10.84M | +0.7% | +$1.15M | <0.01 | |
| State Street | $118.59M | 5.05 | 7.8M | -5.54% | -$6.95M | 0.01 | |
| Millennium Management LLC | $52.99M | 2.25 | 3.48M | +18.96% | +$8.45M | 0.04 | |
| Soleus Capital Management, L.P. | $48.19M | 2.05 | 3.17M | +387.45% | +$38.31M | 0.46 | |
| Wellington Management Company | $47.97M | 2.04 | 3.15M | +0.44% | +$210,339.09 | 0.01 | |
| Geode Capital Management | $47.27M | 2.01 | 3.11M | +0.35% | +$164,261.06 | <0.01 | |
| Opaleye Management Inc | $34.68M | 1.48 | 2.28M | +2.94% | +$988,650.00 | 5.48 | |
| Bank of America | $33.48M | 1.42 | 2.2M | +277.55% | +$24.62M | <0.01 | |
| Sofinnova | $30.19M | 1.28 | 1.98M | New | +$30.19M | 0.06 | |
| Citadel Advisors LLC | $28.57M | 1.22 | 1.88M | +304.41% | +$21.5M | 0.02 | |
| 683 Capital Management Llc | $24.72M | 1.05 | 1.63M | -2.98% | -$760,500.00 | 2.77 | |
| Nuveen | $23.63M | 1.01 | 1.55M | +15.01% | +$3.08M | 0.01 | |
| Hood River Capital Management LLC | $22.42M | 0.95 | 1.47M | New | +$22.42M | 0.5 | |
| Woodline Partners LP | $21.36M | 0.91 | 1.4M | -20.57% | -$5.53M | 0.2 | |
| Fidelity Investments | $21.24M | 0.9 | 1.4M | -11.58% | -$2.78M | <0.01 | |
| Northern Trust | $19.78M | 0.84 | 1.3M | -3.74% | -$768,819.89 | <0.01 | |
| Goldman Sachs | $19.57M | 0.83 | 1.29M | -22.03% | -$5.53M | <0.01 | |
| Morgan Stanley | $17.82M | 0.76 | 1.17M | -21.33% | -$4.83M | <0.01 | |
| Charles Schwab | $17.42M | 0.74 | 1.15M | +1.21% | +$207,966.32 | <0.01 | |
| Susquehanna International Group | $16.46M | 0.7 | 1.08M | -44.46% | -$13.18M | 0.02 | |
| Renaissance Technologies | $12.79M | 0.54 | 840,600 | +0.17% | +$21,294.79 | 0.02 | |
| GHOST TREE CAPITAL LLC | $12.55M | 0.53 | 825,000 | +230% | +$8.75M | 4.08 | |
| Eventide Asset Management | $10.93M | 0.47 | 718,814 | +63.56% | +$4.25M | 0.17 | |
| Cubist Systematic Strategies | $10.39M | 0.44 | 683,013 | +839.07% | +$9.28M | 0.1 | |
| Group One Trading | $9.25M | 0.39 | 608,282 | -38.98% | -$5.91M | 0.27 | |
| Invesco | $8.57M | 0.37 | 563,639 | -20.59% | -$2.22M | <0.01 | |
| ExodusPoint Capital Management, LP | $8.54M | 0.36 | 561,592 | +935.57% | +$7.72M | 0.11 | |
| Rafferty Asset Management Llc | $8.31M | 0.35 | 546,519 | -4.31% | -$374,272.47 | 0.03 | |
| Citigroup | $8.04M | 0.34 | 528,569 | +44.68% | +$2.48M | 0.01 | |
| Jacobs Levy Equity Management | $7.98M | 0.34 | 524,861 | +29.86% | +$1.84M | 0.04 | |
| UBS | $7.98M | 0.34 | 524,622 | -7.12% | -$611,654.97 | <0.01 | |
| Schonfeld Group | $7.47M | 0.32 | 491,098 | +45.66% | +$2.34M | 0.05 | |
| BNY Mellon | $6.76M | 0.29 | 444,122 | -6.24% | -$449,318.37 | <0.01 | |
| JPMorgan Chase | $5.55M | 0.24 | 364,675 | +36.7% | +$1.49M | <0.0001 | |
| Swiss National Bank | $4.32M | 0.18 | 284,100 | +0.53% | +$22,815.00 | <0.01 | |
| Duquesne Family Office Llc | $4.26M | 0.18 | 280,000 | New | +$4.26M | 0.12 | |
| Two Sigma | $4.01M | 0.17 | 263,878 | +70.46% | +$1.66M | 0.01 | |
| Connor Clark & Lunn Investment Management Ltd | $3.53M | 0.15 | 232,347 | -32.89% | -$1.73M | 0.01 | |
| State of Wisconsin Investment Board | $3.41M | 0.15 | 224,224 | +44.44% | +$1.05M | 0.01 | |
| Jane Street Capital | $3.41M | 0.15 | 224,262 | -62.3% | -$5.64M | <0.01 | |
| RhumbLine Advisers | $3.03M | 0.13 | 199,473 | +3.1% | +$91,183.40 | <0.01 | |
| Simplex Trading Llc | $2.89M | 0.12 | 189,849 | -12.8% | -$423,844.55 | 0.09 | |
| Credit Suisse | $2.83M | 0.12 | 186,299 | +0.41% | +$11,529.18 | <0.01 | |
| First Trust | $2.56M | 0.11 | 168,562 | +337.06% | +$1.98M | <0.01 | |
| AllianceBernstein | $2.54M | 0.11 | 167,220 | 0% | +$0 | <0.01 | |
| M28 Capital Management Lp | $2.46M | 0.11 | 161,600 | -25.39% | -$836,550.00 | 2.02 | |
| Ubs Asset Management Americas Inc | $2.46M | 0.11 | 161,927 | 0% | +$0 | <0.01 | |
| Barclays | $2.38M | 0.1 | 156,380 | -63.46% | -$4.13M | <0.01 | |
| Parkman Healthcare Partners Llc | $2.36M | 0.1 | 155,039 | -24.49% | -$764,728.32 | 0.29 |